# Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

> **NCT00002003** · PHASE2 · COMPLETED · sponsor: **Lederle Laboratories**

## Conditions studied

- Lymphoma, Non-Hodgkin
- HIV Infections

## Interventions

- **DRUG:** Mitoxantrone hydrochloride
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT00002003
- **Lead sponsor:** Lederle Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002003, "Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00002003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*